公开(公告)号：US20250154149A1

公开(公告)日：2025-05-15

申请号：US18839000

申请日：2023-02-14

Applicant: Betta Pharmaceuticals Co., Ltd.

Inventor： Xiaofeng XU ,  Xizhen SONG ,  Xintao ZHAO ,  Yan XU ,  Liang CHEN ,  Hongfei RONG ,  Zongquan LI ,  Xiangyong LIU ,  Lieming DING ,  Jiabing WANG

IPC: C07D471/04 ,  A61K31/4985 ,  A61P35/00

Abstract: The present invention relates to a pharmaceutical composition comprising a compound as shown in formula I, and use of the pharmaceutical composition in treating diseases. The present invention also relates to a method for preparing the compound as shown in formula I.

公开(公告)号：US20230022091A1

公开(公告)日：2023-01-26

申请号：US17898258

申请日：2022-08-29

Applicant: Betta Pharmaceuticals Co., Ltd.

Inventor： Yan XU ,  Xiaofeng XU ,  Jiabing WANG ,  Lieming DING

IPC: C07D519/00 ,  C07D471/06

Abstract: The invention relates to a bromodomain inhibitor. The invention also provides compositions and formulations comprising such compounds, and methods of using and preparing such compounds.